4 research outputs found

    Himbacine-Derived Thrombin Receptor Antagonists: C<sub>7</sub>‑Aminomethyl and C<sub>9a</sub>-Hydroxy Analogues of Vorapaxar

    No full text
    We have synthesized several C<sub>7</sub>-aminomethyl analogues of vorapaxar that are potent PAR-1 antagonists. Many of these analogues showed excellent in vitro binding affinity and pharmacokinetics profile in rats. Compound <b>6a</b> from this series showed excellent PAR-1 activity (<i>K</i><sub>i</sub> = 5 nM). We have also synthesized a C<sub>9a</sub>-hydroxy analogue of vorapaxar, which showed very good PAR-1 affinity (<i>K</i><sub>i</sub> = 19.5 nM) along with excellent rat pharmacokinetic profile and ex vivo efficacy in the cynomolgus monkey

    Himbacine-Derived Thrombin Receptor Antagonists: C<sub>7</sub>‑Spirocyclic Analogues of Vorapaxar

    No full text
    We have synthesized several C<sub>7</sub>-spirocyclic analogues of vorapaxar and evaluated their in vitro activities against PAR-1 receptor. Some of these analogues showed activities and rat plasma levels comparable to vorapaxar. Compound <b>5c</b> from this series showed excellent PAR-1 activity (<i>K</i><sub>i</sub> = 5.1 nM). We also present a model of these spirocyclic compounds docked to the PAR-1 receptor based on the X-ray crystal structure of vorapaxar bound to PAR-1 receptor. This model explains some of the structure–activity relationships in this series
    corecore